PCV53 COST-UTILITY ANALYSIS OF EPROSARTAN COMPARED TO ENALAPRIL AND RAMIPRIL IN THE TREATMENT OF MODERATE TO SEVERE HYPERTENSION IN SWEDEN
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63669-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)63669-8/fulltext
Title :
PCV53 COST-UTILITY ANALYSIS OF EPROSARTAN COMPARED TO ENALAPRIL AND RAMIPRIL IN THE TREATMENT OF MODERATE TO SEVERE HYPERTENSION IN SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63669-8&doi=10.1016/S1098-3015(10)63669-8
First page :
Section Title :
Open access? :
No
Section Order :
519